ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1408	National Cancer Institute	Html	en	Grief, Bereavement, and Coping With Loss (PDQ®)–Health Professional Version	Expert-reviewed report about grief, bereavement, and feelings of loss in survivors of someone who has died of cancer. Grief in children is also discussed.	normal grief process 0.581221 unanticipated grief 0.551516 IPT 0.463911 depressive symptoms 0.559773 loss 0.542758 common emotional reactions 0.45155 children 0.526047 interpersonal problems 0.458662 middle phase 0.464448 Health care providers 0.455228 grief counseling exists. 0.565426 grief 0.933904 anticipatory grief 0.744484 health care professionals 0.481565 unanticipated death differs 0.464542 exposure therapy 0.455194 bereaved people 0.453892 grief experiences 0.564377 grief reactions 0.683036 minimal grief reaction—a 0.565 age range 0.479943 grief symptoms 0.544738 deceased person 0.466915 grief intensity 0.535236	necessary grieving process 0.451469 social reactions 0.450213 select grief assessment 0.557139 normal grief 0.697811 death 0.578011 grief bursts 0.548077 IPT group 0.456027 cancer experience 0.45206 grieving process 0.505158 chronic grief reactions 0.566742 complicated grief 0.62885 term anticipatory grief 0.59229 health care 0.509332 common grief reactions 0.572313 pathologic grief reactions 0.569264 normal emotional process 0.454248 bereaved persons 0.498553 severe grief reactions 0.591257 grief disorder 0.543808 actual death 0.478188 grief treatment 0.548186 bereaved persons experience 0.472239 grief experience 0.541082 stage models 0.450278	CLICK HERE
1484	National Cancer Institute	Html	en	Pituitary Tumors Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of pituitary tumors.	treatment 0.39139 diagnostic imaging choice 0.347546 magnetic resonance imaging 0.340677 pituitary tumors 0.690926 pituitary adenomas 0.92392 medical therapy exists. 0.351515 pituitary lesion 0.527537 transsphenoidal microsurgical approach 0.343275 visual field 0.394767 cell-type specific presentations 0.354594 medical therapy 0.38784 pituitary gland 0.541344 gonadotroph adenomas 0.356536 important clinical presentation 0.355104 pituitary carcinomas 0.731658 useful diagnostic tool 0.338617 inactive pituitary adenomas 0.650057 endocrine-inactive adenomas 0.359468 pituitary adenoma 0.802139 pituitary apoplexy 0.612406 hormone-producing adenomas 0.35841 Conventional radiation therapy 0.361094 functional criteria 0.339781 GH-receptor antagonists 0.338498	adjunctive radiation therapy 0.355238 MRI scan 0.341418 effective medical treatment 0.350208 pituitary disorders 0.546502 appropriately selected patients 0.348512 dopamine analogues 0.357798 pituitary tumor 0.625147 Sagittal T1-weighted images 0.340975 patients 0.403665 surgically high-risk patients 0.358813 adjunctive medical therapy 0.353866 Hormone-secreting pituitary carcinomas 0.652967 significant suprasellar extension 0.453203 safe surgical treatment 0.370545 gross total tumor 0.361957 surgical management 0.338442 pituitary adenoma literature 0.647061 pituitary neoplasms 0.533177 postoperative radiation therapy 0.355824 radiation therapy 0.637553 somatostatin analogues 0.402133 ergot-derived dopamine agonists 0.339339 pituitary tumors. 0.521498	CLICK HERE
1525	National Cancer Institute	Html	en	Prostate Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of prostate cancer.	Gleason score 0.479579 stage II prostate 0.274733 prostate gland 0.299389 Digital rectal exam 0.35449 body 0.293669 advanced prostate cancer 0.31933 PDQ cancer information 0.312303 clinical trial search 0.317203 PSA level 0.375326 clinical trials 0.630272 metastatic prostate cancer 0.326945 cancer information summary 0.293408 clinical trial 0.478353 prostate cancer cells 0.379555 patients 0.279925 stage III prostate 0.274165 radiation therapy 0.706978 beam radiation therapy 0.284995 radioactive seeds 0.279855 Recurrent prostate cancer 0.344704 treatment 0.475447 prostate biopsy 0.278369 magnetic resonance imaging 0.29143 general information 0.285325 NCI-supported cancer 0.281722	cancer cells 0.470422 standard radiation therapy 0.280665 radical prostatectomy 0.336986 treatment clinical trials 0.285008 radioactive material 0.277278 National Cancer Institute 0.336961 Prostate Cancer Treatment 0.329429 high-intensity–focused ultrasound therapy 0.287706 hormone therapy 0.461026 benign prostatic hyperplasia 0.328811 new treatment 0.295081 external radiation therapy 0.479863 stage IV prostate 0.27349 prostate cancer 0.898521 cancer clinical trials 0.332604 prostate surgery 0.277806 prostate cancer surgery 0.324678 internal radiation therapy 0.335143 high PSA level 0.327595 cancer 0.953437 information 0.335184 standard treatment 0.325661 early-stage prostate cancer 0.320186 Transrectal ultrasound 0.294546	CLICK HERE
1999	National Cancer Institute	Html	es	Tratamiento de los astrocitomas infantiles (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de los astrocitomas infantiles.	siguientes procedimientos 0.509449 células madre 0.756546 siguientes aspectos 0.541249 efectos secundarios meses 0.505608 sustancia llamada fcev 0.432048 prueba mib-1 0.42502 vía oral 0.416944 encéfalo benignos 0.476825 único tratamiento 0.445679 proteína cinasa.Los inhibidores 0.434623 glioma coroideo 0.430143 escasas ocasiones 0.429534 células t 0.452739 efectos tardíos 0.580441 estrella llamadas 0.429847 PDQ Efectos tardíos 0.459317 National Cancer Institute 0.412326 tumores benignos 0.512758 siguientes riesgos 0.412382	alto recién 0.437854 Instituto Nacional 0.422716 PDQ Tratamiento 0.437378 determinados cambios 0.429353 neurofibromatosis tipo 0.592389 tanta cantidad 0.426418 presente sección 0.412644 nuevos tipos 0.4212 siguientes casos 0.43033 sistema nervioso central 0.991625 Physician Data Query 0.447246 siguientes partes 0.443422 cuánto tumor 0.508299 cuerpo.ampliar derivación 0.416932 células cancerosas.Hay 0.455449 panel derecho 0.460499 siguientes sumarios 0.465245 vasos sanguíneos 0.616892	CLICK HERE
2062	National Cancer Institute	Html	es	Exámenes para detectar el cáncer colorrectal y los pólipos	Hoja informativa que describe las ventajas y desventajas de varios exámenes selectivos de detección del cáncer colorrectal.	fecal usa anticuerpos 0.492705 screening flexible sigmoidoscopy 0.428806 colonography without 0.411418 alta sensibilidad 0.434525 Screening colonoscopy 0.418332 colorectal-cancer screening 0.417889 Circulating tumour markers 0.417801 Schoen RE 0.427721 randomized controlled trials 0.418478 historial médico 0.412157 rectal cancers 0.41141 define patients with 0.416784 personas morirán 0.419825 flexible sigmoidoscopy screening 0.425333 seguro médico 0.427103 Preventive Services Task 0.418828 digital rectal examination 0.417389 bario ayuda 0.41421 prueba adn-fit 0.46424 pequeñas cantidades 0.431615 prospective evaluation 0.428506 Internal Medicine 0.490577 materia fecal usa 0.61279 Estados Unidos 0.627755 PubMed Abstract 0.909181	única prueba 0.462783 fecal occult blood 0.543844 sangre llamada 0.43281 versus fecal occult 0.484081 Noninvasive testing 0.410836 computed tomographic colonography 0.451989 principales factores 0.410616 prospective multicenter study 0.41765 regular —por ejemplo 0.423251 General Internal Medicine 0.422201 Servicios Preventivos 0.435789 controlled trial 0.42874 PLoS Medicine 0.414525 methylated sept9 0.411171 riesgo promedio 0.720816 fecal immunochemical testing 0.480317 Affairs Cooperative Study 0.41697 computadora ensambla 0.410696 llamada dcbe 0.410601 llamada fit 0.414186 pequeño riesgo 0.422784 cuáles pruebas 0.470698 necesarios procedimientos 0.459521 New England Journal 0.448594	CLICK HERE
3597	National Cancer Institute	Html	en	MERIT Award Recipient: Laimonis A. Laimins, Ph.D.	MERIT Award Recipient: Laimonis A. Laimins, Ph.D.	productive life cycle 0.692492 anti-viral therapies 0.414992 long-term objective 0.415026 viral particles 0.475434 viral factor 0.465899 HPV types 0.533205 Viral infection 0.48447 HPV proteins functions 0.60071 proliferative lesions 0.427068 stratified epithelial cells 0.554619 E4 protein 0.416206 small DNA viruses 0.509754 development 0.367942 life cycle 0.732336 tissue culture 0.408683 cervical cancer 0.697893 anogenital cancers 0.416749 viral replication 0.470226 pathogenesis 0.323941 certain types 0.427907 late viral functions 0.551387 HPV functions 0.507234 genetic analyses 0.407346 HPV infections 0.62415 activation 0.321394	productive viral life 0.570807 blocks infection 0.430045 E5 protein 0.409072 differentiation 0.394198 HPVs 0.330868 methods 0.33537 virion assembly 0.42345 genome amplification 0.41342 human papillomaviruses 0.908593 Oncogenic Papillomaviruses 0.574563 organotypic cultures 0.4081 normal cells 0.43284 suprabasal cells 0.432461 cases 0.370169 effective anti-virals 0.431518 epithelial cells 0.561264 protein synthesis 0.412779 HPV viral proteins 0.658868 vaccine 0.388142 Additional studies 0.403147 future 0.32145 cell death pathway 0.503149 high-risk types 0.424894 grant 0.339966	CLICK HERE
15632	National Cancer Institute	Html	null	NCI Grant Application Development, Submission, and Award	Learn how the six-step process of the NCI grants process works— from application development, to peer review, to post-award administration.			CLICK HERE
16844	National Cancer Institute	Html	en	Ohio State University and University of Kentucky — Optimizing RNA Nanoparticle's Size and Shape for Enhancing Cancer Targeting and Treatment	A systematic characterization of RNA nanoparticle behavior, in vitro and in vivo, to optimize its cellular delivery to triple negative breast cancer (TNBC).	optimized therapeutic systems 0.528757 varying shapes 0.305417 moieties 0.241586 endosomal escape 0.300775 RNA nanoparticle behavior 0.817424 optimum shape 0.346242 project team 0.300326 vivo delivery 0.345174 overall goal 0.318652 therapeutic components 0.373072 Jianhua Yu 0.345836 tumor regression 0.318722 Enhancing Cancer Targeting 0.687284 William Carson 0.342459 internalization/intracellular trafficking 0.315312 efficient therapeutic delivery 0.542327 surgical oncology 0.297773	delivery systems 0.312116 pharmacokinetic profiles 0.331727 Daniel Pack 0.340086 Ohio State University 0.5489 nanoparticle size 0.433341 gene therapy 0.299174 RNA nanoparticles 0.513535 negative breast cancer 0.501323 facile chemical processing 0.476016 rna nanoparticle 0.954079 Principal Investigators 0.353961 Peixuan Guo 0.400645 favorable biodistribution 0.529957 molecular / cell 0.296003 cancer immunotherapy 0.325509 systematic studies 0.315425 systematic characterization 0.33975	CLICK HERE
16863	National Cancer Institute	Html	es	Selected Vegetables y Sun's Soup (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos sobre el uso de Selected Vegetables y Sun's Soup como tratamiento para personas con cáncer. Nota: La información contenida en este sumario ya no se actualiza y se ofrece solo con fines de consulta.	Centro Nacional 0.402144 pequeño número 0.40122 estadio iv 0.404103 New Hampshire Avenue 0.401505 Drug Administration 0.400937 Sun’s Soup 0.535838 NCI Best Case 0.4027 Sun's Soup 0.648887 Selected Vegetables 0.997532 mezcla original hongos 0.402938 fitoquímicos anticancerígenos 0.401555 Freeze-dried Selected Vegetables 0.409927 datos bibliográficos pubmed 0.401627 siguientes ingredientes 0.401955 siguientes preguntas 0.400938 cuerpo usa 0.401378 Dátil rojo 0.401496 siguientes riesgos 0.401219 Scutellaria barbata 0.401858	Instituto Nacional 0.408304 Salud Complementaria 0.403343 Visuals Online 0.401103 siguientes versiones 0.401582 complementarias revisa 0.401573 Physician Data Query 0.406378 personas enfermas 0.401456 Estados Unidos 0.461182 libre uso 0.401151 mezcla contenía hongos 0.402782 efectos secundarios dañinos 0.402436 página manejo 0.401027 ¿El tratamiento 0.402145 ¿Los beneficios 0.40095 juntos cam 0.400907 hierbas hedyotis 0.40184 Series Program 0.400934 medicina complementaria 0.443276	CLICK HERE
17231	National Cancer Institute	Html	es	Secuenciación del ADN de tumores en el tratamiento de cáncer	null	mutaciones impulsoras 0.72633 Investigación Clínica Proteómica 0.72046 MATCH Infantil 0.761796 máquina llamada secuenciador 0.847349 llamada secuenciación 0.960353	Darryl Leja 0.794924 gen egfr 0.773791 llamadas paneles 0.73634 mayoría surgen 0.7646	CLICK HERE